Clinical Pathway for Pancreatic Enzyme Replacement Therapy (PERT) in Children with or at Risk for Exocrine Pancreatic Insufficiency (EPI)
Clinical Pathway for Pancreatic Enzyme Replacement Therapy (PERT) in Children with or at Risk for Exocrine Pancreatic Insufficiency (EPI)
Goals
- Standardize Diagnosis of EPI
- Standardize Pancreatic Enzyme Replacement Therapy Dosing
- Ensure Expert Consultation
Metrics
- Improve % of patients with adequate weight gain and growth
- Decrease % of patients with total starting daily dose over 10,000 lipase units/kg/day
- A minimum of 75% of initial oral and enteral PERT orders will meet recommended initial dose guidelines